When will the Bacitracin Ophthalmic Ointment shortage end?

FDA gives no end date, and no manufacturer posted a recovery estimate for this listing.

Does FDA list alternatives to Bacitracin Ophthalmic Ointment?

No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.

Is Bacitracin Ophthalmic Ointment in shortage?

Label: plusbeauxjours · shortage label · not a prescription, not a pharmacy, not FDA

IN SHORTAGE

Bacitracin Ophthalmic Ointment: in shortage

Eye ointments

A generic eye ointment, not your medicine. We draw dosage forms, not products, and never pills you could match to yours.

Reason: “Discontinuation of the manufacture of the drug”. FDA shortage reason (FDASIA), reported by the manufacturer

DRUG

Bacitracin Ophthalmic Ointment

FDA LISTING

Bacitracin Ophthalmic Ointment

FORM

eye ointment

STATUS

Currently in Shortage

FIRST POSTED

Mar 3, 2025

LAST FDA UPDATE

Jun 1, 2026

AS OF

Oct 24, 2026

SOURCE

FDA Drug Shortages ↗ (opens in a new tab)

FDA lists 1 presentation: 1 unavailable · 0 limited · 0 available.

FDA Drug Shortages checked Oct 24, 2026, 21:05 ET · FDA updates daily · manufacturer-reported

Information from FDA’s drug shortage list, reported by manufacturers. Not medical advice. Don’t stop, change or ration a medicine without talking to your prescriber or pharmacist.

FDA's listing, word for word: Bacitracin Ophthalmic Ointment. 1 presentation from 1 maker.

Check your own medication, form and strength

What to ask at the counter

Is this a supply problem at this pharmacy, or everywhere? Could another pharmacy have it? FDA consumer FAQ (opens in a new tab)
Is my strength or the maker you stock affected? FDA list, by presentation
Is there an alternative to this medicine I should ask my prescriber about? FDA consumer FAQ (opens in a new tab)
When should I check back, or can you order it?

FDA: “talk with your health care provider or pharmacist for other treatment options during the shortage.” FDA Drug Shortages page (opens in a new tab)

This listing on FDA ↗ (opens in a new tab)Report a shortage to FDA: drugshortages@fda.hhs.gov

Every presentation FDA lists, by maker

Availability is FDA's text for each package, as the manufacturer reported it. Makers with unavailable or limited packages come first.

Padagis US LLC1 presentation · 1 unavailable

Contact (FDA's listing): 866-634-9120

3.5 g
Bacitracin, Ophthalmic Ointment, 3.5 g (NDC 0574-4022-35)
Shortage is estimated for 24 months
NDC 0574-4022-35Revised Jun 1, 2026
Unavailable

What the manufacturers told FDA

No recovery estimate posted by the makers.

Reason for the shortage (FDASIA)

Discontinuation of the manufacture of the drug

As reported by the manufacturer under the Food and Drug Administration Safety and Innovation Act.

Alternatives

FDA lists none: “Providing a list of alternative drug products for a drug in shortage is part of the ‘practice of medicine.’ FDA does not regulate the practice of medicine.” Your prescriber or pharmacist can talk through options with you. ASHP also tracks shortages and suggested alternatives (different criteria) ↗ (opens in a new tab)

Questions

Is Bacitracin Ophthalmic Ointment in shortage?: Yes. As of Oct 24, 2026, FDA lists Bacitracin Ophthalmic Ointment as currently in shortage: 1 presentations, 1 unavailable and 0 limited.
When will the Bacitracin Ophthalmic Ointment shortage end?: FDA gives no end date, and no manufacturer posted a recovery estimate for this listing.
Does FDA list alternatives to Bacitracin Ophthalmic Ointment?: No. FDA calls a list of alternatives part of the ‘practice of medicine’. Ask your pharmacist or prescriber.